CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Financiere de Tubize SA Company Snapshot
Financiere de Tubize SA operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Financiere de Tubize SA with three other pharmaceutical manufacturers in Europe: Valneva SE of FRANCE (2019 sales of 126.20 million Euros [US$142.59 million] of which 103% was Commercialized Vaccines), Abcam PLC of UNITED KINGDOM (£259.90 million [US$328.16 million] of which 100% was Sales of antibodies and related products), and Laboratorios Farmaceuticos Rovi S.A. which is based in SPAIN (381.31 million Euros [US$430.86 million] of which 83% was Marketing).

Sales Analysis. Financiere de Tubize SA reported sales of 286.08 million Euro (US$323.25 million) for the year ending December of 2019. This represents a decrease of 0.8% versus 2018, when the company's sales were 288.25 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Financiere de Tubize SA
  Stock Performance Chart for Financiere de Tubize SA
 
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 84.20
(Figures in Euros )
1 Week 1.6%   13 Weeks 20.3%  
4 Weeks 25.5%   52 Weeks 39.6%  
 
Financiere de Tubize SA Key Data:
  Ticker: TUB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 286,076,000
(Year Ending Jan 2020).
Employees: 1
  Currency: Euros Market Cap: 3,230,435,640
  Fiscal Yr Ends: December Shares Outstanding: 38,366,219
  Share Type: Actions Ordinaires Closely Held Shares: 25,307,333
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.